0.1850
+0.0200
+(12.12%)
At close: April 16 at 3:40:37 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Jonathan M. N. Rigby M.B.A., MBA | CEO & Director | 693.4k | -- | 1968 |
| Mr. James T. Parsons CPA-CA, MAcc | Chief Financial Officer | 467.18k | -- | 1965 |
| Dr. Frank Shannon M.D. | Senior VP of Clinical Development and Regulatory Affairs | 335.83k | -- | -- |
| Dr. Modestus Obochi M.B.A., Ph.D. | Chief Business Officer | 499.49k | -- | -- |
| Mr. David Burke | Vice President of Investor Relations | -- | -- | -- |
| Ms. Marylyn Rigby | Chief Communications Officer | -- | -- | -- |
| Dr. Pericles Calias Ph.D. | Chief Development Officer and Head of R&D | -- | -- | 1968 |
Sernova Biotherapeutics Inc
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 17
Description
Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. The comoany was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc is headquartered in London, Canada.
Corporate Governance
Sernova Biotherapeutics Inc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 17, 2025 at 8:00 PM UTC - March 21, 2025 at 8:00 PM UTC
Sernova Biotherapeutics Inc Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
BETR.CN BetterLife Pharma Inc.
0.0850
0.00%
RKV.V Rakovina Therapeutics Inc.
0.0450
-10.00%
CYTO.V Cytophage Technologies Ltd.
0.1850
+85.00%
XRTX.V XORTX Therapeutics Inc.
1.3400
+8.06%
XRTX XORTX Therapeutics Inc.
0.8620
-2.05%
NGEN.V NervGen Pharma Corp.
2.9800
-0.33%
VX1.BE Vertex Pharmaceuticals Inc
436.40
+0.43%
MDNA.TO Medicenna Therapeutics Corp.
1.0000
+11.11%
TTI.V Thiogenesis Therapeutics, Corp.
0.5600
0.00%
ONC.TO Oncolytics Biotech Inc.
0.7800
-8.24%